Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ann Marshak-Rothstein
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Anatomy
Physiology
Disorders
Sign-in to see full Profile
Network (preview)
21
Ju, Shyr-Te
18
Rifkin, Ian
14
Rothstein, Thomas
13
Shlomchik, Mark
9
Viglianti, Gregory
8
Foote, Linda
8
Busconi, Liliana
7
Hohlbaum, Andreas
6
Leadbetter, Elizabeth
6
Xiao, Sheng
6
Akira, Shizuo
5
Weigert, Martin
5
Saff, Rebecca
5
Sherr, David
5
Beaudette, Britte
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ann Marshak-Rothstein (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Avalos Ana M; Latz Eicke; Mousseau Betty; Christensen Sean R; Shlomchik Mark J; Lund Frances; Marshak-Rothstein Ann
Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(10):6262-8.
-
2009: Yasuda Kei; Richez Christophe; Uccellini Melissa B; Richards Rocco J; Bonegio Ramon G; Akira Shizuo; Monestier Marc; Corley Ronald B; Viglianti Gregory A; Marshak-Rothstein Ann; Rifkin Ian R
Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(5):3109-17.
-
2009: Green Nathaniel M; Laws Amy; Kiefer Kerstin; Busconi Liliana; Kim You-Me; Brinkmann Melanie M; Trail Erin Hodges; Yasuda Kei; Christensen Sean R; Shlomchik Mark J; Vogel Stefanie; Connor John H; Ploegh Hidde; Eilat Dan; Rifkin Ian R; van Seventer Jean Maguire; Marshak-Rothstein Ann
Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(3):1569-76.
-
2009: Lenert Petar; Yasuda Kei; Busconi Liliana; Nelson Patrice; Fleenor Courtney; Ratnabalasuriar Radhika S; Nagy Peter L; Ashman Robert F; Rifkin Ian R; Marshak-Rothstein Ann
DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Faslpr/lpr mice in vivo.
Arthritis research & therapy 2009;11(3):R79.
-
2009: Uccellini Melissa B; Avalos Ana M; Marshak-Rothstein Ann; Viglianti Gregory A
Toll-like receptor-dependent immune complex activation of B cells and dendritic cells.
Methods in molecular biology (Clifton, N.J.) 2009;517():363-80.
-
2008: Uccellini Melissa B; Busconi Liliana; Green Nathaniel M; Busto Patricia; Christensen Sean R; Shlomchik Mark J; Marshak-Rothstein Ann; Viglianti Gregory A
Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(9):5875-84.
-
2007: Gregory Meredith S; Saff Rebecca R; Marshak-Rothstein Ann; Ksander Bruce R
Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.
Cancer research 2007;67(24):11951-8.
-
2007: Marshak-Rothstein Ann; Ohashi Pamela S
Intricate connections between innate and adaptive autoimmunity.
Current opinion in immunology 2007;19(6):603-5.
-
2007: Busconi Liliana; Bauer Jason W; Tumang Joseph R; Laws Amy; Perkins-Mesires Kristin; Tabor Abigail S; Lau Christina; Corley Ronald B; Rothstein Thomas L; Lund Frances E; Behrens Timothy W; Marshak-Rothstein Ann
Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(11):7397-405.
-
2007: Yasuda Kei; Richez Christophe; Maciaszek Joseph W; Agrawal Neerja; Akira Shizuo; Marshak-Rothstein Ann; Rifkin Ian R
Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(11):6876-85.
-
2007: Tian Jane; Avalos Ana Maria; Mao Su-Yau; Chen Bo; Senthil Kannaki; Wu Herren; Parroche Peggy; Drabic Stacey; Golenbock Douglas; Sirois Cherilyn; Hua Jing; An Ling Ling; Audoly Laurent; La Rosa Greg; Bierhaus Angelika; Naworth Peter; Marshak-Rothstein Ann; Crow Mary K; Fitzgerald Katherine A; Latz Eicke; Kiener Peter A; Coyle Anthony J
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.
Nature immunology 2007;8(5):487-96.
-
2007: Lafyatis Robert; Marshak-Rothstein Ann
Toll-like receptors and innate immune responses in systemic lupus erythematosus.
Arthritis research & therapy 2007;9(6):222.
-
2007: Marshak-Rothstein Ann; Rifkin Ian R
Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.
Annual review of immunology 2007;25():419-41.
-
2006: Marshak-Rothstein Ann
Toll-like receptors in systemic autoimmune disease.
Nature reviews. Immunology 2006;6(11):823-35.
-
2006: Lafyatis Robert; York Michael; Marshak-Rothstein Ann
Antimalarial agents: closing the gate on Toll-like receptors?
Arthritis and rheumatism 2006;54(10):3068-70.
-
2006: Marshak-Rothstein Ann
Tolling for autoimmunity-prime time for 7.
Immunity 2006;25(3):397-9.
-
2006: Beaudette-Zlatanova Britte C; Ling Tina; Shlomchik Mark J; Marshak-Rothstein Ann; Rifkin Ian R
B cells and dendritic cells from V kappa 8 light chain transgenic mice activate MRL-lpr/gld CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(1):45-52.
-
2006: Busconi Liliana; Lau Christina M; Tabor Abigail S; Uccellini Melissa B; Ruhe Zachary; Akira Shizuo; Viglianti Gregory A; Rifkin Ian R; Marshak-Rothstein Ann
DNA and RNA autoantigens as autoadjuvants.
Journal of endotoxin research 2006;12(6):379-84.
-
2005: Lau Christina M; Broughton Courtney; Tabor Abigail S; Akira Shizuo; Flavell Richard A; Mamula Mark J; Christensen Sean R; Shlomchik Mark J; Viglianti Gregory A; Rifkin Ian R; Marshak-Rothstein Ann
RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
The Journal of experimental medicine 2005;202(9):1171-7.
-
2005: Gregory Meredith S; Koh Sean; Huang Eric; Saff Rebecca R; Marshak-Rothstein Ann; Mukai Shizuo; Ksander Bruce R
A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilege.
Investigative ophthalmology & visual science 2005;46(7):2495-502.
-
2005: William Jacqueline; Euler Chad; Leadbetter Elizabeth; Marshak-Rothstein Ann; Shlomchik Mark J
Visualizing the onset and evolution of an autoantibody response in systemic autoimmunity.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(11):6872-8.
-
2005: Rifkin Ian R; Leadbetter Elizabeth A; Busconi Liliana; Viglianti Gregory; Marshak-Rothstein Ann
Toll-like receptors, endogenous ligands, and systemic autoimmune disease.
Immunological reviews 2005;204():27-42.
-
2004: Funatake Castle J; Dearstyne Erica A; Steppan Linda B; Shepherd David M; Spanjaard Elena S; Marshak-Rothstein Ann; Kerkvliet Nancy I
Early consequences of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on the activation and survival of antigen-specific T cells.
Toxicological sciences : an official journal of the Society of Toxicology 2004;82(1):129-42.
-
2004: Marshak-Rothstein Ann; Busconi Liliana; Rifkin Ian R; Viglianti Gregory A
The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunity.
Rheumatic diseases clinics of North America 2004;30(3):559-74, ix.
-
2004: Boulé Melissa W; Broughton Courtney; Mackay Fabienne; Akira Shizuo; Marshak-Rothstein Ann; Rifkin Ian R
Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.
The Journal of experimental medicine 2004;199(12):1631-40.
-
2004: Saff Rebecca R; Spanjaard Elena S; Hohlbaum Andreas M; Marshak-Rothstein Ann
Activation-induced cell death limits effector function of CD4 tumor-specific T cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):6598-606.
-
2004: Xiao Sheng; Zhang Xingmin; Mann Koren K; Jodo Satoshi; Li Li; Jarjour Wael N; Marshak-Rothstein Ann; Sherr David H; Ju Shyr-Te
Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
International immunology 2004;16(5):759-66.
-
2004: Marshak-Rothstein Ann; Busconi Liliana; Lau Christina M; Tabor Abigail S; Leadbetter Elizabeth A; Akira Shizuo; Krieg Arthur M; Lipford Grayson B; Viglianti Gregory A; Rifkin Ian R
Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells.
Journal of endotoxin research 2004;10(4):247-51.
-
2003: Viglianti Gregory A; Lau Christina M; Hanley Timothy M; Miko Benjamin A; Shlomchik Mark J; Marshak-Rothstein Ann
Activation of autoreactive B cells by CpG dsDNA.
Immunity 2003;19(6):837-47.
-
2003: Rifkin Ian R; Marshak-Rothstein Ann
T-bet: the Toll-bridge to class-switch recombination?
Nature immunology 2003;4(7):650-2.
-
2003: Leadbetter Elizabeth A; Rifkin Ian R; Marshak-Rothstein Ann
Toll-like receptors and activation of autoreactive B cells.
Current directions in autoimmunity 2003;6():105-22.
-
2002: Xiao Sheng; Jodo Satoshi; Sung Sun-Sang J; Marshak-Rothstein Ann; Ju Shyr-Te
A novel signaling mechanism for soluble CD95 ligand. Synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-kappaB nuclear translocation.
The Journal of biological chemistry 2002;277(52):50907-13.
-
2002: Gregory Meredith S; Repp Amanda C; Holhbaum Andreas M; Saff Rebecca R; Marshak-Rothstein Ann; Ksander Bruce R
Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(5):2727-35.
-
2002: Hohlbaum Andreas M; Saff Rebecca R; Marshak-Rothstein Ann
Fas-ligand--iron fist or Achilles' heel?
Clinical immunology (Orlando, Fla.) 2002;103(1):1-6.
-
2002: Leadbetter Elizabeth A; Rifkin Ian R; Hohlbaum Andreas M; Beaudette Britte C; Shlomchik Mark J; Marshak-Rothstein Ann
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
Nature 2002;416(6881):603-7.
-
2001: Hohlbaum A M; Gregory M S; Ju S T; Marshak-Rothstein A
Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(11):6217-24.
-
2001: Xiao S; Marshak-Rothstein A; Ju S T
Sp1 is the major fasl gene activator in abnormal CD4(-)CD8(-)B220(+) T cells of lpr and gld mice.
European journal of immunology 2001;31(11):3339-48.
-
2001: Jodo S; Xiao S; Hohlbaum A; Strehlow D; Marshak-Rothstein A; Ju S T
Apoptosis-inducing membrane vesicles. A novel agent with unique properties.
The Journal of biological chemistry 2001;276(43):39938-44.
-
2000: Jodo S; Hohlbaum A M; Xiao S; Chan D; Strehlow D; Sherr D H; Marshak-Rothstein A; Ju S T
CD95 (Fas) ligand-expressing vesicles display antibody-mediated, FcR-dependent enhancement of cytotoxicity.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5487-94.
-
2000: Rifkin I R; Leadbetter E A; Beaudette B C; Kiani C; Monestier M; Shlomchik M J; Marshak-Rothstein A
Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(3):1626-33.
-
2000: Zhu B; Beaudette B C; Rifkin I R; Marshak-Rothstein A
Double mutant MRL-lpr/lpr-gld/gld cells fail to trigger lpr-graft-versus-host disease in syngeneic wild-type recipient mice, but can induce wild-type B cells to make autoantibody.
European journal of immunology 2000;30(6):1778-84.
-
2000: Gochuico B R; Zhang J; Ma B Y; Marshak-Rothstein A; Fine A
TRAIL expression in vascular smooth muscle.
American journal of physiology. Lung cellular and molecular physiology 2000;278(5):L1045-50.
-
2000: Hohlbaum A M; Moe S; Marshak-Rothstein A
Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.
The Journal of experimental medicine 2000;191(7):1209-20.
-
2000: Wang J K; Ju S T; Marshak-Rothstein A
Protection of T cells from activation-induced cell death by Fas+ B cells.
European journal of immunology 2000;30(3):931-7.
-
2000: Boes M; Schmidt T; Linkemann K; Beaudette B C; Marshak-Rothstein A; Chen J
Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(3):1184-9.
-
1999: Xiao S; Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Widom R L; Ju S T
FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3.
European journal of immunology 1999;29(11):3456-65.
-
1999: Rifkin I R; Marshak-Rothstein A
Fas and Fas ligand in autoimmunity.
Current directions in autoimmunity 1999;1():31-55.
-
1998: Rifkin I R; Channavajhala P L; Kiefer H L; Carmack A J; Landesman-Bollag E; Beaudette B C; Jersky B; Salant D J; Ju S T; Marshak-Rothstein A; Seldin D C
Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(10):5164-70.
-
1998: Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Ju S T
Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3469-73.
-
1998: Taccioli G E; Amatucci A G; Beamish H J; Gell D; Xiang X H; Torres Arzayus M I; Priestley A; Jackson S P; Marshak Rothstein A; Jeggo P A; Herrera V L
Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity.
Immunity 1998;9(3):355-66.
-
1998: Foote L C; Marshak-Rothstein A; Rothstein T L
Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded.
The Journal of experimental medicine 1998;187(6):847-53.
-
1997: Wang J K; Zhu B; Ju S T; Tschopp J; Marshak-Rothstein A
CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.
Cellular immunology 1997;179(2):153-64.
-
1997: Jacobson B A; Foote L C; Panka D J; Ju S T; Rothstein T L; Marshak-Rothstein A
Unique site of autoantibody production in Fas-deficient mice.
Annals of the New York Academy of Sciences 1997;815():218-29.
-
1997: Foote L C; Marshak-Rothstein A; Rothstein T L
Inducible Fas-resistance mediated by IL-4 in activated B cells.
Annals of the New York Academy of Sciences 1997;815():114-5.
-
1997: Jacobson B A; Rothstein T L; Marshak-Rothstein A
Unique site of IgG2a and rheumatoid factor production in MRL/lpr mice.
Immunological reviews 1997;156():103-10.
-
1996: Jacobson B A; Rothstein T L; Marshak-Rothstein A
The role of Fas/FasL interactions in the regulation of B cell function.
Behring Institute Mitteilungen 1996;(97):185-99.
-
1996: Foote L C; Howard R G; Marshak-Rothstein A; Rothstein T L
IL-4 induces Fas resistance in B cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(7):2749-53.
-
1996: Foote L C; Schneider T J; Fischer G M; Wang J K; Rasmussen B; Campbell K A; Lynch D H; Ju S T; Marshak-Rothstein A; Rothstein T L
Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(5):1878-85.
-
1996: Perkins D L; Listman J A; Marshak-Rothstein A; Kozlow W; Kelley V R; Finn P W; Rimm I J
Restriction of the TCR repertoire inhibits the development of memory T cells and prevents autoimmunity in lpr mice.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(12):4961-8.
-
1996: Ozdemirli M; El-Khatib M; Foote L C; Wang J K; Marshak-Rothstein A; Rothstein T L; Ju S T
Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses.
European journal of immunology 1996;26(2):415-9.
-
1996: Cui H; el-Khatib M; Sherr D H; Ettinger R; Sy M S; Marshak-Rothstein A; Ju S T
Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation.
Cellular immunology 1996;167(2):302-12.
-
1996: Cui H; Sherr D H; el-Khatib M; Matsui K; Panka D J; Marshak-Rothstein A; Ju S T
Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function.
Cellular immunology 1996;167(2):276-84.
-
1996: Rothstein T L; Foote L C; Schneider T J; Fischer G M; Jacobson B A; Lynch D H; Ju S T; Marshak-Rothstein A
Inducible resistance to Fas-mediated apoptosis in primary B lymphocytes.
Advances in experimental medicine and biology 1996;406():177-89.
-
1995: Jacobson B A; Panka D J; Nguyen K A; Erikson J; Abbas A K; Marshak-Rothstein A
Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice.
Immunity 1995;3(4):509-19.
-
1995: Ettinger R; Panka D J; Wang J K; Stanger B Z; Ju S T; Marshak-Rothstein A
Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(9):4302-8.
-
1995: Rothstein T L; Wang J K; Panka D J; Foote L C; Wang Z; Stanger B; Cui H; Ju S T; Marshak-Rothstein A
Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.
Nature 1995;374(6518):163-5.
-
1995: Ju S T; Panka D J; Cui H; Ettinger R; el-Khatib M; Sherr D H; Stanger B Z; Marshak-Rothstein A
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.
Nature 1995;373(6513):444-8.
-
1995: Panka D J; Salant D J; Jacobson B A; Minto A W; Marshak-Rothstein A
The effect of VH residues 6 and 23 on IgG3 cryoprecipitation and glomerular deposition.
European journal of immunology 1995;25(1):279-84.
-
1994: Singer G G; Carrera A C; Marshak-Rothstein A; Martínez C; Abbas A K
Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model.
Current opinion in immunology 1994;6(6):913-20.
-
1994: Shan H; Shlomchik M J; Marshak-Rothstein A; Pisetsky D S; Litwin S; Weigert M G
The mechanism of autoantibody production in an autoimmune MRL/lpr mouse.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(11):5104-20.
-
1994: Jacobson B A; Sharon J; Shan H; Shlomchik M; Weigert M G; Marshak-Rothstein A
An isotype switched and somatically mutated rheumatoid factor clone isolated from a MRL-lpr/lpr mouse exhibits limited intraclonal affinity maturation.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(9):4489-99.
-
1994: Ju S T; Cui H; Panka D J; Ettinger R; Marshak-Rothstein A
Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(10):4185-9.
-
1994: Ettinger R; Wang J K; Bossu P; Papas K; Sidman C L; Abbas A K; Marshak-Rothstein A
Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(4):1557-68.
-
1993: Very D L; Panka D J; Weissman D; Wysocki L; Manser T; Marshak-Rothstein A
Lack of connectivity between the induced and autoimmune repertoires of lpr/lpr mice.
Immunology 1993;80(4):518-26.
-
1993: Bossu P; Singer G G; Andres P; Ettinger R; Marshak-Rothstein A; Abbas A K
Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(12):7233-9.
-
1993: Levine J S; Pugh B J; Hartwell D; Fitzpatrick J M; Marshak-Rothstein A; Beller D I
Interleukin-1 dysregulation is an intrinsic defect in macrophages from MRL autoimmune-prone mice.
European journal of immunology 1993;23(11):2951-8.
-
1993: Panka D J; Very D L; Jacobson B A; Kussie P H; Parhami-Seren B; Margolies M N; Marshak-Rothstein A
Defining the structural correlates responsible for loss of arsonate affinity in an IDCR antibody isolated from an autoimmune mouse.
Molecular immunology 1993;30(11):1013-20.
-
1992: Glaser R M; Mahon C A; Marshak-Rothstein A
Persistence of lpr/lpr-derived IgG2a secreting B cells in normal----lpr/lpr adult radiation chimeras or lpr/lpr----normal kidney capsule chimeras.
Cellular immunology 1992;142(2):313-25.
-
1992: Berney T; Fulpius T; Shibata T; Reininger L; Van Snick J; Shan H; Weigert M; Marshak-Rothstein A; Izui S
Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass.
International immunology 1992;4(1):93-9.
-
1990: Glaser R M; Marshak-Rothstein A
Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages.
European journal of immunology 1990;20(9):1917-25.
-
1990: Perkins D L; Glaser R M; Mahon C A; Michaelson J; Marshak-Rothstein A
Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(2):549-55.
-
1990: Traish A M; Ettinger R; Kim N; Marshak-Rothstein A; Wotiz H H
Development and characterization of monoclonal antibodies to a specific domain of human estrogen receptor.
Steroids 1990;55(5):196-208.
-
1990: Shlomchik M; Mascelli M; Shan H; Radic M Z; Pisetsky D; Marshak-Rothstein A; Weigert M
Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.
The Journal of experimental medicine 1990;171(1):265-92.
-
1989: Wolfowicz C B; Lyons S; Mahon C A; Marshak-Rothstein A; Rothstein T L
Isolation of self-recognizing IgG2a monoclonal rheumatoid factors.
Clinical immunology and immunopathology 1989;52(2):313-22.
-
1989: Marshak-Rothstein A
Origins of autoantibodies.
Current opinion in immunology 1989;1(4):697-700.
-
1988: Wolfowicz C B; Sakorafas P; Rothstein T L; Marshak-Rothstein A
Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice.
Clinical immunology and immunopathology 1988;46(3):382-95.
-
1987: Perkins D L; Michaelson J; Glaser R M; Marshak-Rothstein A
Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(5):1406-13.
-
1987: Shlomchik M J; Marshak-Rothstein A; Wolfowicz C B; Rothstein T L; Weigert M G
The role of clonal selection and somatic mutation in autoimmunity.
Nature 1987;328(6133):805-11.
-
1987: Perkins D L; Michaelson J; Marshak-Rothstein A
The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(2):466-9.
-
1985: Weissman D; Parker D J; Rothstein T L; Marshak-Rothstein A
Methods for the production of xenogeneic monoclonal antibodies in murine ascites.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2):1001-3.
-
1985: Weissman D; Rothstein T L; Marshak-Rothstein A
A rapid method for comparing monoclonal antibodies by limited proteolysis and electrophoresis.
Hybridoma 1985;4(4):329-39.
-
1984: Rothstein T L; Miller R A; Parker D J; Kelly E; Vastola A P; Marshak-Rothstein A
Induction of idiotope suppression in the anti-azophenylarsonate response of T-depleted A/J mice.
The Journal of experimental medicine 1984;159(4):1283-8.
Sign-in to see more
